Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 18)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
9-Feb-10 New Constructs, LLC N/A MNKD: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
9-Feb-10 Pechala's Reports Lubomir Pechala MANNKIND CORPORATION (MNKD=US) - REPORT FOR ACTIVE TRADERS 4 $25 View Abstract
9-Feb-10 ValuEngine, Inc. N/A ValuEngine Industry Report for DRUGS 18 $49 View Abstract
8-Feb-10 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for MNKD 13 $25 View Abstract
8-Feb-10 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
7-Feb-10 Pechala's Reports Frantisek Pechala MANNKIND CP (MNKD=US) 12-months forecast 1 $15 View Abstract
7-Feb-10 PriceTarget Research, Inc. N/A Drug Intelligence Monitor: overall outlook NEUTRAL - 25 new Leaders; 25 new Laggards. 65 $20 View Abstract
6-Feb-10 Standard & Poor's Quantitative Report N/A MannKind Corp 6 $25 View Abstract
6-Feb-10 Pechala's Reports Lubomir Pechala MANNKIND CP (MNKD=US) 2-weeks forecast 1 $10 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: MANNKIND CORP -- MNKD 1 $4 View Abstract
Next 8

Brokerage Reports (Showing 1 to 1 of 1)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
4-Feb-10 Griffin Securities, Inc. Keith Markey Griffin Securities Updates Coverage on MannKind Corp. (MNKD) 5 $10 View Abstract

Independent Reports (Showing 1 to 10 of 17)

Release
Date Contributor Author Title Pages Price More Info
9-Feb-10 New Constructs, LLC N/A MNKD: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
9-Feb-10 Pechala's Reports Lubomir Pechala MANNKIND CORPORATION (MNKD=US) - REPORT FOR ACTIVE TRADERS 4 $25 View Abstract
9-Feb-10 ValuEngine, Inc. N/A ValuEngine Industry Report for DRUGS 18 $49 View Abstract
8-Feb-10 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for MNKD 13 $25 View Abstract
8-Feb-10 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract
7-Feb-10 Pechala's Reports Frantisek Pechala MANNKIND CP (MNKD=US) 12-months forecast 1 $15 View Abstract
7-Feb-10 PriceTarget Research, Inc. N/A Drug Intelligence Monitor: overall outlook NEUTRAL - 25 new Leaders; 25 new Laggards. 65 $20 View Abstract
6-Feb-10 Standard & Poor's Quantitative Report N/A MannKind Corp 6 $25 View Abstract
6-Feb-10 Pechala's Reports Lubomir Pechala MANNKIND CP (MNKD=US) 2-weeks forecast 1 $10 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: MANNKIND CORP -- MNKD 1 $4 View Abstract
Next 7

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.